Hormonal contraceptives : Do patients understand the real benefits and risks? Should IVF patients be allowed to choose a baby's gender? Women should push when they feel the urge Keeping solvent in a recession
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More